Wolverine Trading’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Wolverine Trading’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,023	Closed	-$267K	–	5241
2023 Q1	$267K	Buy	+11,023	New	+$138K	﹤0.01%	3138
2022 Q4	–	Sell	-13,114	Closed	-$58K	–	5391
2022 Q3	$58K	Buy	+13,114	New	+$59.8K	﹤0.01%	4108
2022 Q1	–	Sell	-10,661	Closed	-$61K	–	6810
2021 Q4	$61K	Buy	+10,661	New	+$67.7K	﹤0.01%	5271
2021 Q3	–	Sell	-35,356	Closed	-$299K	–	7250
2021 Q2	$299K	Buy	+35,356	New	+$285K	﹤0.01%	4424

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wolverine Trading's PRVB Position: Q2 2023 in Review

Wolverine Trading sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 11,023 shares — an estimated $267K sold.

Wolverine Trading first reported a position in PRVB in Q2 2021 and held it in 4 quarters. The position peaked at $299K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Wolverine Trading reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Wolverine Trading sold 11,023 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $267K.
Wolverine Trading first reported a position in Provention Bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Wolverine Trading's Provention Bio, Inc. Common Stock position peaked at $299K in Q2 2021.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.